Geneos Wealth Management Inc. Lowers Holdings in Globe Life Inc. $GL

Geneos Wealth Management Inc. decreased its position in shares of Globe Life Inc. (NYSE:GL) by 46.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,277 shares of the company’s stock after selling 2,835 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Globe Life were worth $456,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Hilton Head Capital Partners LLC bought a new position in Globe Life during the 4th quarter worth about $30,000. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life in the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc purchased a new stake in shares of Globe Life in the 2nd quarter worth approximately $31,000. Torren Management LLC purchased a new stake in shares of Globe Life in the 4th quarter worth approximately $37,000. Finally, AdvisorNet Financial Inc boosted its stake in shares of Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

NYSE GL opened at $184.55 on Tuesday. The firm’s fifty day simple moving average is $167.16 and its two-hundred day simple moving average is $151.92. The firm has a market capitalization of $14.33 billion, a P/E ratio of 12.76 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 12-month low of $120.05 and a 12-month high of $191.55.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the company posted $3.07 EPS. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts forecast that Globe Life Inc. will post 15.64 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Insiders Place Their Bets

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the business’s stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $8,231,603.58. The trade was a 38.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. The trade was a 15.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 124,187 shares of company stock valued at $19,529,414. 2.11% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages recently commented on GL. TD Cowen boosted their price objective on shares of Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Truist Financial lifted their price target on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Morgan Stanley boosted their price target on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. Finally, Jefferies Financial Group upped their price objective on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $184.60.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.